Detalles de la búsqueda
1.
[Comparison of two insulin glargine formulations: biosimilar vs. reference product]. / Zwei Insulin-glargin-Formulierungen im Vergleich : Biosimilar versus Originalpräparat.
MMW Fortschr Med;
158 Suppl 5: 19-27, 2016 08.
Artículo
en Alemán
| MEDLINE | ID: mdl-27565486
2.
Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus.
Clin Sci (Lond);
119(8): 345-51, 2010 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-20509857
3.
Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen device.
Diabetes Technol Ther;
11(2): 87-92, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19848574
4.
Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
Clin Ther;
30(12): 2252-62, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19167585
5.
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
Metabolism;
56(4): 491-6, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17379006
6.
Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitus.
Clin Lab;
53(3-4): 193-8, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17447657
7.
IRIS II study: intact proinsulin is confirmed as a highly specific indicator for insulin resistance in a large cross-sectional study design.
Diabetes Technol Ther;
7(3): 478-86, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15929679
8.
Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
Diabetes Care;
27(3): 682-7, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-14988285
9.
The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix study.
J Diabetes Sci Technol;
5(2): 426-32, 2011 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21527115
10.
Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.
J Diabetes Sci Technol;
4(4): 976-82, 2010 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20663464
11.
Postprandial vascular effects of VIAject compared with insulin lispro and regular human insulin in patients with type 2 diabetes.
Diabetes Care;
33(1): 116-20, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19808913
12.
Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim study.
Diabetes Technol Ther;
12(8): 599-604, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20615100
13.
Combined pioglitazone and metformin treatment maintains the beneficial effect of short-term insulin infusion in patients with type 2 diabetes: results from a pilot study.
J Diabetes Sci Technol;
3(6): 1442-50, 2009 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20144400
14.
Reliability of lightguide spectrophotometry (O2C) for the investigation of skin tissue microvascular blood flow and tissue oxygen supply in diabetic and nondiabetic subjects.
J Diabetes Sci Technol;
2(6): 1151-6, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19885305
15.
Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus.
Gynecol Endocrinol;
23(6): 356-60, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17616862
16.
Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus.
Clin Chem Lab Med;
44(5): 556-60, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16681424
Resultados
1 -
16
de 16
1
Próxima >
>>